Sort
78,016 grants matching “breast cancer”
Early Detection Research Network (EDRN) BiomarkerReferenceResourceCenter (BRRC)
$721,387National Cancer Institute · Y01 · FY2010 · CA
RESEARCH CORE
$721,344Catarina I Kiefe · University Of Alabama At Birmingham · P60 · FY2010 · MD
Insulin Resistance and Breast Cancer Prognosis in Black & White Women
$721,329Nina A Bickell · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · CA
Predicting Breast Cancer Risk after Benign Percutaneous Biopsy
$721,306Mark E Sherman · Mayo Clinic Jacksonville · R01 · FY2020 · CA
Novel Markers for Disease Outcome in Breast Cancer
$721,279Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Molecular Determinants of Inflammatory Breast Cancer
$721,200Gayathri Devi · Duke University · R01 · FY2025 · CA
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
$721,121Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
POLYOMA HOST INTERACTIONS LEADING TO TUMOR DEVELOPMENT
$720,803Harvard University (Medical School) · R01 · FY2002 · CA
Computational approaches for the analyses of spatial profiling technologies
$720,674Peng Jiang · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Surgical navigation system for in-bore MRI-guided breast interventions
$720,639Erez Nevo · Robin Medical, Inc. · R44 · FY2008 · CA
REDUCTION OF TRIGLYCERIDES IN WOMEN ON HRT
$720,614University Of Pittsburgh At Pittsburgh · R01 · FY2005 · HL
Ontario Familial Breast Cancer Registry
$720,409Irene L. Andrulis · Cancer Care Ontario · U01 · FY2009 · CA
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$720,328Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Characterizing genetic risk of cancer across diverse populations through multi-ancestry epigenome profiling and chromatin QTL discovery
$720,252Sylvan C. Baca · Dana-Farber Cancer Inst · U01 · FY2025 · CA
The EPICS (Engaging Primary care in Cancer Survivorship) study: A trial of novel models of care for cancer survivors
$720,173Erin Elizabeth Hahn · Kaiser Foundation Research Institute · R01 · FY2023 · CA
TARGETING CRYPTIC SPLICING-DERIVED NEOANTIGENS IN HNRNPM-DYSREGULATED TRIPLE-NEGATIVE BREAST CANCER
$720,000Baylor College Of Medicine · · FY2025 · Defense Health Agency
Huntsman Cancer Institute/Univ of Utah Network Lead Academic Participating Site
$719,900David K Gaffney · University Of Utah · U10 · FY2014 · CA
A Pathway for Necrotic Cell Death
$719,845David J Shapiro · University Of Illinois At Urbana-Champaign · R01 · FY2025 · CA
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor
$719,820Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Determining the Impact of Metabolic Adaptations on the Immune-Tumor Microenvironment in Metastatic Breast Cancer
$719,799Subhamoy Dasgupta · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Breast Cancer and the Environment Research Center
$719,782Michigan State University · U01 · FY2004 · ES
Probing cytosolic nucleic acid sensing pathways in cancer
$719,771Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer
$719,691Semanti Mukherjee · Sloan-Kettering Inst Can Research · R37 · FY2022 · CA
Exosomal Drug Delivery
$719,680Wendy A Spencer · 3p Biotechnologies, Inc. · R44 · FY2017 · CA
Cooperative Human Tissue Network Support through Duke's BioRepository & Precision Pathology Center
$719,670Shannon Jones McCall · Duke University · UM1 · FY2025 · CA